Literature DB >> 33352721

Transferrin Receptors in Erythropoiesis.

Cyrielle Richard1,2, Frédérique Verdier1,2.   

Abstract

Erythropoiesis is a highly dynamic process giving rise to red blood cells from hematopoietic stem cells present in the bone marrow. Red blood cells transport oxygen to tissues thanks to the hemoglobin comprised of α- and β-globin chains and of iron-containing hemes. Erythropoiesis is the most iron-consuming process to support hemoglobin production. Iron delivery is mediated via transferrin internalization by the endocytosis of transferrin receptor type 1 (TFR1), one of the most abundant membrane proteins of erythroblasts. A second transferrin receptor-TFR2-associates with the erythropoietin receptor and has been implicated in the regulation of erythropoiesis. In erythroblasts, both transferrin receptors adopt peculiarities such as an erythroid-specific regulation of TFR1 and a trafficking pathway reliant on TFR2 for iron. This review reports both trafficking and signaling functions of these receptors and reassesses the debated role of TFR2 in erythropoiesis in the light of recent findings. Potential therapeutic uses targeting the transferrin-TFR1 axis or TFR2 in hematological disorders are also discussed.

Entities:  

Keywords:  TFR1; TFR2; erythropoiesis; iron metabolism; iron uptake; transferrin

Mesh:

Substances:

Year:  2020        PMID: 33352721      PMCID: PMC7766611          DOI: 10.3390/ijms21249713

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  87 in total

1.  Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia.

Authors:  Gautam Rishi; Eriza S Secondes; Daniel F Wallace; V Nathan Subramaniam
Journal:  Am J Hematol       Date:  2016-06-12       Impact factor: 10.047

2.  Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes.

Authors:  Augusta Di Savino; Valentina Gaidano; Antonietta Palmieri; Francesca Crasto; Alessandro Volpengo; Roberta Lorenzatti; Patrizia Scaravaglio; Alessandro Manello; Paolo Nicoli; Enrico Gottardi; Giuseppe Saglio; Daniela Cilloni; Marco De Gobbi
Journal:  Br J Haematol       Date:  2016-02-23       Impact factor: 6.998

3.  SRC-mediated phosphorylation of dynamin and cortactin regulates the "constitutive" endocytosis of transferrin.

Authors:  Hong Cao; Jing Chen; Eugene W Krueger; Mark A McNiven
Journal:  Mol Cell Biol       Date:  2009-12-07       Impact factor: 4.272

4.  Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis.

Authors:  Matthias Schranzhofer; Manfred Schifrer; Javier Antonio Cabrera; Stephan Kopp; Peter Chiba; Hartmut Beug; Ernst W Müllner
Journal:  Blood       Date:  2006-01-19       Impact factor: 22.113

5.  Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation.

Authors:  Maura Poli; Sara Luscieti; Valentina Gandini; Federica Maccarinelli; Dario Finazzi; Laura Silvestri; Antonella Roetto; Paolo Arosio
Journal:  Haematologica       Date:  2010-07-15       Impact factor: 9.941

Review 6.  Transferrin receptor 1 in cancer: a new sight for cancer therapy.

Authors:  Ying Shen; Xin Li; Dandan Dong; Bin Zhang; Yanru Xue; Peng Shang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

7.  Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1.

Authors:  Marc A Kerenyi; Florian Grebien; Helmuth Gehart; Manfred Schifrer; Matthias Artaker; Boris Kovacic; Hartmut Beug; Richard Moriggl; Ernst W Müllner
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

8.  Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes.

Authors:  Guillemette Ramey; Jean-Christophe Deschemin; Sophie Vaulont
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

Review 9.  Ferritin drug carrier (FDC) for tumor targeting therapy.

Authors:  Jiuyang He; Kelong Fan; Xiyun Yan
Journal:  J Control Release       Date:  2019-09-05       Impact factor: 9.776

10.  Normal systemic iron homeostasis in mice with macrophage-specific deletion of transferrin receptor 2.

Authors:  Gautam Rishi; Eriza S Secondes; Daniel F Wallace; V Nathan Subramaniam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-11-25       Impact factor: 4.052

View more
  4 in total

1.  A Possible Way to Relate the Effects of SARS-CoV-2-Induced Changes in Transferrin to Severe COVID-19-Associated Diseases.

Authors:  Elek Telek; Zoltán Ujfalusi; Gábor Kemenesi; Brigitta Zana; Ferenc Jakab; Gabriella Hild; András Lukács; Gábor Hild
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

Review 2.  Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents.

Authors:  Pierre V Candelaria; Lai Sum Leoh; Manuel L Penichet; Tracy R Daniels-Wells
Journal:  Front Immunol       Date:  2021-03-17       Impact factor: 7.561

Review 3.  Therapeutic potential of induced iron depletion using iron chelators in Covid-19.

Authors:  Punnoth Poonkuzhi Naseef; Muhammed Elayadeth-Meethal; K T Mohammed Salim; A Anjana; C Muhas; K Abdul Vajid; Mohamed Saheer Kuruniyan
Journal:  Saudi J Biol Sci       Date:  2021-12-13       Impact factor: 4.052

Review 4.  Physiology and Inflammation Driven Pathophysiology of Iron Homeostasis-Mechanistic Insights into Anemia of Inflammation and Its Treatment.

Authors:  Lukas Lanser; Dietmar Fuchs; Katharina Kurz; Günter Weiss
Journal:  Nutrients       Date:  2021-10-22       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.